Premier Fund Managers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $774K | Sell |
5,672
-1,843
| -25% | -$258K | 0.05% | 114 |
|
|
2025
Q4 | $926K | Sell |
7,515
-1,000
| -12% | -$122K | 0.05% | 101 |
|
|
2025
Q3 | $959K | Sell |
8,515
-1,300
| -13% | -$148K | 0.04% | 106 |
|
|
2025
Q2 | $1.09M | Buy |
9,815
+600
| +7% | +$63.9K | 0.04% | 102 |
|
|
2025
Q1 | $1.03M | Sell |
9,215
-6,495
| -41% | -$670K | 0.04% | 110 |
|
|
2024
Q4 | $1.45M | Buy |
15,710
+5,000
| +47% | +$450K | 0.05% | 115 |
|
|
2024
Q3 | $896K | Hold |
10,710
| – | – | 0.03% | 135 |
|
|
2024
Q2 | $737K | Hold |
10,710
| – | – | 0.03% | 135 |
|
|
2024
Q1 | $782K | Buy |
10,710
+846
| +9% | +$65.1K | 0.03% | 129 |
|
|
2023
Q4 | $801K | Sell |
9,864
-800
| -8% | -$62.3K | 0.03% | 127 |
|
|
2023
Q3 | $804K | Hold |
10,664
| – | – | 0.04% | 121 |
|
|
2023
Q2 | $811K | Hold |
10,664
| – | – | 0.03% | 166 |
|
|
2023
Q1 | $869K | Buy |
10,664
+1,518
| +17% | +$126K | 0.03% | 183 |
|
|
2022
Q4 | $779K | Buy |
9,146
+400
| +5% | +$31.7K | 0.03% | 185 |
|
|
2022
Q3 | $552K | Buy |
8,746
+3,346
| +62% | +$211K | 0.04% | 130 |
|
|
2022
Q2 | $337K | Buy |
5,400
+900
| +20% | +$55.7K | 0.02% | 192 |
|
|
2022
Q1 | $269K | Hold |
4,500
| – | – | 0.01% | 204 |
|
|
2021
Q4 | $330K | Buy |
4,500
+500
| +13% | +$34.4K | 0.01% | 189 |
|
|
2021
Q3 | $284K | Hold |
4,000
| – | – | 0.01% | 215 |
|
|
2021
Q2 | $272K | Hold |
4,000
| – | – | 0.01% | 215 |
|
|
2021
Q1 | $262K | Sell |
4,000
-16,204
| -80% | -$1.04M | 0.01% | 211 |
|
|
2020
Q4 | $1.14M | Buy |
20,204
+1,843
| +10% | +$111K | 0.05% | 200 |
|
|
2020
Q3 | $1.14M | Hold |
18,361
| – | – | 0.07% | 181 |
|
|
2020
Q2 | $1.37M | Sell |
18,361
-57,487
| -76% | -$4.41M | 0.09% | 173 |
|
|
2020
Q1 | $5.75M | Buy |
+75,848
| New | +$5.24M | 3.73% | 5 |
|
|
2018
Q2 | – | Sell |
-41,129
| Closed | -$3.08M | – | 48 |
|
|
2018
Q1 | $3.08M | Hold |
41,129
| – | – | 2.55% | 25 |
|
|
2017
Q4 | $2.98M | Buy |
41,129
+1,202
| +3% | +$91.3K | 2.18% | 29 |
|
|
2017
Q3 | $3.23M | Buy |
39,927
+3,662
| +10% | +$280K | 2.33% | 23 |
|
|
2017
Q2 | $2.57M | Hold |
36,265
| – | – | 2.09% | 28 |
|
|
2017
Q1 | $2.45M | Buy |
36,265
+4,762
| +15% | +$335K | 2.11% | 29 |
|
|
2016
Q4 | $2.27M | Buy |
31,503
+26,303
| +506% | +$1.96M | 1.96% | 31 |
|
|
2016
Q3 | $405K | Sell |
5,200
-27,000
| -84% | -$2.19M | 0.33% | 53 |
|
|
2016
Q2 | $2.65M | Buy |
32,200
+5,200
| +19% | +$461K | 2.58% | 23 |
|
|
2016
Q1 | $2.48M | Buy |
27,000
+2,500
| +10% | +$225K | 2.42% | 20 |
|
|
2015
Q4 | $2.5M | Buy |
+24,500
| New | +$2.55M | 2.35% | 20 |
|
Other funds holding GILD
VCM
VPM
Premier Fund Managers's GILD Position: Q1 2026 in Review
Premier Fund Managers reduced its Gilead Sciences (GILD) stake by 25% in Q1 2026, selling an estimated $258K and leaving 5,672 shares worth $774K. The position accounts for 0.05% of the portfolio, ranked #114.
Premier Fund Managers first reported a position in GILD in Q4 2015 and has held it in 35 quarters since. The position peaked at $5.75M in Q1 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Premier Fund Managers held 5,672 shares of Gilead Sciences worth $774K as of Q1 2026.
- Premier Fund Managers sold 1,843 Gilead Sciences shares in Q1 2026, an estimated $258K.
- Gilead Sciences made up 0.05% of Premier Fund Managers's portfolio in Q1 2026, its #114 holding.
- Premier Fund Managers first reported a position in Gilead Sciences in Q4 2015 and has held it in 35 quarters since.
- Premier Fund Managers's Gilead Sciences position peaked at $5.75M in Q1 2020.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Premier Fund Managers's 13F filing for Q1 2026, filed 14 May 2026.